4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-20-031626
President and CEO sold 40,542 shares at an average $37.84 ($1,534,061)
- President and CEO acquired 40,542 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Lucchino David L. · President and CEO
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-14 | Exercise or conversion : show line 1 in the form | +13,514 | $0.61 | $8,244 | 337,314 | D |
| 2020-12-14 | Sale : show line 2 in the form | −13,514 | $35.12 | $474,612 | 323,800 | D |
| 2020-12-15 | Exercise or conversion : show line 3 in the form | +6,411 | $0.61 | $3,911 | 330,211 | D |
| 2020-12-15 | Exercise or conversion : show line 4 in the form | +7,103 | $0.61 | $4,333 | 337,314 | D |
| 2020-12-15 | Sale : show line 5 in the form | −9,014 | $38.18 | $344,155 | 328,300 | D |
| 2020-12-15 | Sale : show line 6 in the form | −4,500 | $38.83 | $174,735 | 323,800 | D |
| 2020-12-16 | Exercise or conversion : show line 7 in the form | +13,514 | $0.61 | $8,244 | 337,314 | D |
| 2020-12-16 | Sale : show line 8 in the form | −13,514 | $40.00 | $540,560 | 323,800 | D |
| Open-market sales · 40,542 sh · avg $37.84 · $1,534,061 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-12-14 | Exercise or conversion : show line 9 in the form Stock Option | −13,514 | $0.61 | 2027-06-28 | 13,514 | 10,324 | D |
| 2020-12-15 | Exercise or conversion : show line 10 in the form Stock Option | −6,411 | $0.61 | 2027-06-28 | 6,411 | 3,913 | D |
| 2020-12-15 | Exercise or conversion : show line 11 in the form Stock Option | −7,103 | $0.61 | 2028-05-21 | 7,103 | 303,544 | D |
| 2020-12-16 | Exercise or conversion : show line 12 in the form Stock Option | −13,514 | $0.61 | 2028-05-21 | 13,514 | 290,030 | D |
Loading xslF345X03/form4.xml…